Literature DB >> 16257123

Analysis of the PINK1 gene in a cohort of patients with sporadic early-onset parkinsonism in Taiwan.

Hon-Chung Fung1, Chiung-Mei Chen, John Hardy, Andrew B Singleton, Guey-Jen Lee-Chen, Yih-Ru Wu.   

Abstract

Mutations in the PINK1 gene have been shown to cause autosomal recessive Parkinson's disease (PD) and/or early onset sporadic PD in Italy, Spain, North America, Ireland, and Asia. However, there are limited data on PINK1 mutations in sporadic early onset Asian PD patients. To determine the prevalence of PINK1 mutation in Taiwanese population, we conducted genetic analysis of PINK1 mutation in 73 early onset sporadic PD and 94 normal control subjects. We only identified a novel single heterozygous mutation R 407Q mutation in exon 6 of this gene in one patient at the age onset of 54. Overall, these data indicate that PINK1 mutations are rare in our population. Based on our results, unless common mutational hotspots are identified, routine testing for this mutation at least in our population may not be cost-effective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257123     DOI: 10.1016/j.neulet.2005.10.005

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration.

Authors:  Jun Peng; May Lin Oo; Julie K Andersen
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

Review 2.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

3.  HTRA2 variations in Taiwanese Parkinson's disease.

Authors:  Chiung-Mei Chen; Chun-Hsien Wu; Chin-Hsia Hsieh; Chih-Hsin Lin; I-Cheng Chen; Yi-Chun Chen; Li-Ching Lee; Chi-Mei Lee; Yung-Che Tseng; Guey-Jen Lee-Chen; Yih-Ru Wu
Journal:  J Neural Transm (Vienna)       Date:  2013-12-12       Impact factor: 3.575

Review 4.  The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity.

Authors:  David N Hauser; Christopher T Primiani; Mark R Cookson
Journal:  Curr Protein Pept Sci       Date:  2017       Impact factor: 3.272

5.  Mitochondrial DNA polymorphisms and the risk of Parkinson's disease in Taiwan.

Authors:  C M Chen; C C Kuan; G-J Lee-Chen; Y R Wu
Journal:  J Neural Transm (Vienna)       Date:  2007-03-15       Impact factor: 3.575

6.  VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease.

Authors:  Qingmin Ruan; Adam J Harrington; Kim A Caldwell; Guy A Caldwell; David G Standaert
Journal:  Neurobiol Dis       Date:  2009-10-20       Impact factor: 5.996

Review 7.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

8.  FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease.

Authors:  Chiung-Mei Chen; I-Cheng Chen; Yi-Cheng Huang; Hsueh-Fen Juan; Ying-Lin Chen; Yi-Chun Chen; Chih-Hsin Lin; Li-Ching Lee; Chi-Mei Lee; Guey-Jen Lee-Chen; Yun-Ju Lai; Yih-Ru Wu
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

9.  Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.

Authors:  Ronny Myhre; Stina Steinkjer; Alice Stormyr; Gina L Nilsen; Hiba Abu Zayyad; Khalid Horany; Mohamad K Nusier; Helge Klungland
Journal:  BMC Neurol       Date:  2008-12-16       Impact factor: 2.474

10.  T313M polymorphism of the PINK1 gene in Parkinson's disease.

Authors:  Qin Luo; Xinling Yang; Yani Yao; Hongjuan Li; Yuling Wang
Journal:  Exp Ther Med       Date:  2014-05-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.